The Kidney Disease: improving Global Outcomes website: comparison of guidelines as a tool for harmonization. (Q49168187)

18 February 2018

title

The Kidney Disease: improving Global Outcomes website: comparison of guidelines as a tool for harmonization. (English)

1 reference

18 February 2018

author

Jonathan Craig

5

1 reference

18 February 2018

Sadayoshi Itō

6

1 reference

18 February 2018

Carmine Zoccali

9

1 reference

18 February 2018

author name string

Vanbelleghem H

1

1 reference

18 February 2018

Vanholder R

2

1 reference

18 February 2018

Levin NW

3

1 reference

18 February 2018

Becker G

4

1 reference

18 February 2018

Lau J

7

1 reference

18 February 2018

Locatelli F

8

1 reference

18 February 2018

Solez K

10

1 reference

18 February 2018

Hales M

11

1 reference

18 February 2018

Lameire N

12

1 reference

18 February 2018

Eknoyan G

13

1 reference

18 February 2018

language of work or name

English

0 references

publication date

21 March 2007

1 reference

18 February 2018

published in

Kidney International

1 reference

18 February 2018

volume

71

1 reference

18 February 2018

issue

10

1 reference

18 February 2018

page(s)

1054-1061

1 reference

18 February 2018

Guidelines in general practice: the new Tower of Babel?

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002177

7 January 2021

ESRD patients in 2001: global overview of patients, treatment modalities and development trends

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002177

7 January 2021

Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002177

7 January 2021

Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002177

7 January 2021

Prevalence of kidney damage in Australian adults: The AusDiab kidney study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002177

7 January 2021

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002177

7 January 2021

Chronic kidney disease as cause of cardiovascular morbidity and mortality

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002177

7 January 2021

Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002177

7 January 2021

Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002177

7 January 2021

Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Preventi

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002177

7 January 2021

The burden of kidney disease: improving global outcomes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002177

7 January 2021

Quantitating hemodialysis: a comparison of three kinetic models

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002177

7 January 2021

The post-hemodialysis rebound: predicting and quantifying its effect on Kt/V

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002177

7 January 2021

Comparison of methods to predict equilibrated Kt/V in the HEMO Pilot Study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002177

7 January 2021

Effect of the hemodialysis prescription of patient morbidity: report from the National Cooperative Dialysis Study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002177

7 January 2021

Relationship of dose of hemodialysis and cause-specific mortality

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002177

7 January 2021

The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002177

7 January 2021

Effect of dialysis dose and membrane flux in maintenance hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002177

7 January 2021

Grading evidence and recommendations for clinical practice guidelines in nephrology. A position statement from Kidney Disease: Improving Global Outcomes (KDIGO).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002177

7 January 2021

The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002177

7 January 2021

Association between recombinant human erythropoietin and quality of life and exercise capacity of patients receiving haemodialysis. Canadian Erythropoietin Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002177

7 January 2021

Predialysis versus postdialysis hematocrit evaluation during erythropoietin therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002177

7 January 2021

Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002177

7 January 2021

Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002177

7 January 2021

Association of hyperphosphataemia with haemodynamic disturbances in end-stage renal disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002177

7 January 2021

The impact of haematocrit levels and erythropoietin treatment on overall and cardiovascular mortality and morbidity--the experience of the Lombardy Dialysis Registry

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002177

7 January 2021

Anaemia in haemodialysis patients of five European countries: association with morbidity and mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002177

7 January 2021

The cost-effectiveness of maintaining higher hemoglobin targets with erythropoietin in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002177

7 January 2021

Randomised controlled trial of the READER method of critical appraisal in general practice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002177

7 January 2021

Grading quality of evidence and strength of recommendations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002177

7 January 2021

Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: the AGREE project

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002177

7 January 2021

The number, quality, and coverage of randomized controlled trials in nephrology.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002177

7 January 2021

Identifiers

DOI

10.1038/SJ.KI.5002177

1 reference

18 February 2018

Dimensions Publication ID

1052196909

0 references

1 reference

18 February 2018